FDA updates labeling for TUZISTRA XR
Labeling changes approved for TRIS PHARMA INC. Active ingredient: CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX. Decision date: 12/22/2025
Labeling changes approved for TRIS PHARMA INC. Active ingredient: CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX. Decision date: 12/22/2025
There are no comments here yet...